Influenza vaccine in cardiovascular disease: time to move the needle-Reference-Cited by-同舟云学术

Influenza vaccine in cardiovascular disease: time to move the needle

Published:2022-08-28 Issue:41 Volume:43 Page:4389-4391
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Vardeny Orly¹^ORCID

Affiliation:

1. Center for Care Delivery and Outcomes Research, Minneapolis Veterans Administration Health Care System, University of Minnesota , One Veterans Drive, Minneapolis, MN 55417 , USA

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/eurheartj/advance-article-pdf/doi/10.1093/eurheartj/ehac491/45581036/ehac491.pdf

Reference11 articles.

1. Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland;Warren-Gash;Eur Respir J,2018

2. Acute myocardial infarction after laboratory-confirmed influenza infection;Kwong;N Engl J Med,2018

3. Role of acute infection in triggering acute coronary syndromes;Corrales-Medina;Lancet Infect Dis,2010

4. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology;Davis;J Am Coll Cardiol,2006

5. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis;Udell;JAMA,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing higher-dose and single standard-dose influenza vaccines in preventing cardiovascular events: a meta-analysis with 68,713 patients;Public Health;2024-10

2. From Inflammation to Acute Cardiovascular Events – a Complex Journey;Journal of Cardiovascular Emergencies;2024-06-01

3. In-Hospital influenza vaccination to prevent cardiorespiratory events in the first 45 days after acute coronary syndrome: A prespecified analysis of the VIP-ACS trial;Vaccine;2024-01

4. Acute Coronary Syndrome in Older Adults: an Update from the 2022 Scientific Statement by the American Heart Association;Heart, Vessels and Transplantation;2023-01-14

5. Sodium–glucose co-transporter 2 inhibition: the saga continues;European Heart Journal;2022-11-01